2LEBV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 2LEBV, covering 2024-10-30 to 2024-10-30. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection [Phase 4]